0001127602-21-030300.txt : 20211203
0001127602-21-030300.hdr.sgml : 20211203
20211203211730
ACCESSION NUMBER: 0001127602-21-030300
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211202
FILED AS OF DATE: 20211203
DATE AS OF CHANGE: 20211203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANSTICE DAVID W
CENTRAL INDEX KEY: 0001181171
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 211471762
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-12-02
0001520262
Alkermes plc.
ALKS
0001181171
ANSTICE DAVID W
CONNAUGHT HOUSE
1 BURLINGTON ROAD
DUBLIN 4 IRELAND
1
Ordinary Shares
2021-12-02
4
M
0
5578
A
78659
D
Ordinary Shares
2021-12-02
4
F
0
1339
22.11
D
77320
D
Restricted Stock Unit Award
2021-12-02
4
M
0
5578
D
Ordinary Shares
5578
0
D
Each restricted stock unit represents a contingent right to receive one ordinary share.
This award is fully vested in accordance with its terms.
/s/ Stephanie Roche, attorney-in-fact for David W. Anstice
2021-12-03